Form 4 for MRK Merck & Co.
Accepted 2025-05-02 00:00:00 ET · period of report 2025-04-30 · accession 0001127602-25-013174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-02 | 2025-04-30 | MRK | Larson Betty D | EVP, Chief HR Off | F - Tax | $84.71 | -5,153 | 6,197 | -45% | -$436.5K |
| D | 2025-05-02 | 2025-04-30 | MRK | Larson Betty D | EVP, Chief HR Off | M - OptEx | $84.71 | +11.3K | 11.3K | New | +$961.5K |
| D | 2025-05-02 | 2025-04-30 | MRK | Larson Betty D | EVP, Chief HR Off | M - OptEx | $0.00 | -11.3K | 22.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-30 | F | D | 5,153 | $84.71 | 6,197 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-30 | M | A | 11,350 | $84.71 | 11,350 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-04-30 | M | D | 11,350 | $0.00 | 22,700 | D | — · 2025-04-30 to 2027-04-30 | 11,350 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F2) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. |